Fulgent Genetics FLGT
NASDAQ FLGT
$21.69 -0.16 (-0.73%)
At close: Sep 18, 2026 · 4:00 PM EDT

Fulgent Genetics (FLGT) Other financing activities (2017 - 2026)

Fulgent Genetics' (FLGT) quarterly Other financing activities came in at $2000.0 in Q2 2026, down 77.78% quarter-over-quarter from $9000.0 in Q1 2026.

Analysis

Fulgent Genetics (FLGT) Other financing activities (2017 - 2026) Analysis & Trends

Fulgent Genetics has disclosed Other financing activities across 7 years of filings, most recently posting $2000.0 for Q2 2026.

  • In Q2 2026, Other financing activities changed N/A year-over-year to $2000.0; the TTM figure through Jun 2026 stood at $11000.0 (changed N/A YoY), while the FY2025 annual figure was $1000.0, down 98.04% from the prior year.
  • Other financing activities came in at $2000.0 for Q2 2026 at Fulgent Genetics, down from $9000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $16000.0 in Q1 2022 to a low of $2000.0 in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Fulgent Genetics 596.80 Mn 334.14 Mn 25.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Mar 31, 2026 9,000.00
Dec 31, 2022 12,000.00
Jun 30, 2022 3,000.00
Mar 31, 2022 16,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 17,000.00
Jun 30, 2021 24,000.00
Mar 31, 2021 44,000.00
Dec 31, 2020 2,000.00
Sep 30, 2020 62,000.00
Jun 30, 2020 28,000.00
Mar 31, 2020 12,000.00
Dec 31, 2019 12,000.00
Sep 30, 2019 17,000.00
Jun 30, 2019 5,000.00
Mar 31, 2019 4,000.00
Dec 31, 2018 5,000.00
Sep 30, 2018 1,000.00
Jun 30, 2018 7,000.00